Massachusetts · 194th Legislature (2025-2026) · Bill
S 1603: An Act to conduct a public health study of synthetic drugs in the commonwealth
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 1603 is a bill introduced in the Massachusetts Senate on February 27, 2025. According to its official title, it concerns: An Act to conduct a public health study of synthetic drugs in the commonwealth. Primary sponsor: Patrick O'Connor (Republican). Most recent recorded action (December 4, 2025): Accompanied a study order, see S2790.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Mr. O'Connor, a petition (accompanied by bill, Senate, No. 1603) of Patrick M. O'Connor for legislation to conduct a public health study of synthetic drugs in the commonwealth. Public Health.
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Patrick O'Connor | Primary sponsor | Republican | Senate | First Plymouth and Norfolk |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Accompanied a study order, see S2790
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- House concurred
- Referred to the committee on Public Health